Ross Baker

机构：Royal College of Surgeons in Ireland, Murdoch University, Australian Red Cross Lifeblood, Hollywood Private Hospital, Hvidovre Hospital, Copenhagen University Hospital, Department of the Premier and Cabinet, Irish Blood Transfusion Service, Avenir Health · ORCID：0000-0002-2728-6788

发表论文 236 篇 · 总被引 11062 次 · h-index 47

代表论文

• Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma (2024 · New England Journal of Medicine · 被引 103)
• Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial (2025 · The Lancet Infectious Diseases · 被引 24)
• Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial (2024 · The Lancet Haematology · 被引 24)
• 2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri‐operative and bleeding management (2025 · Internal Medicine Journal · 被引 23)
• The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1 (2024 · Blood · 被引 20)
• Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (2025 · Journal of Clinical Oncology · 被引 18)